Device
Mepilex
Mepilex is a medical device with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Withdrawn1
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
withdrawn133%
completed133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Pressure Injury Prevention in AE and PFC
NCT03924622
completednot_applicable
Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®
NCT00742183
withdrawnphase_2
Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds
NCT01790763
Clinical Trials (3)
Showing 3 of 3 trials
NCT03924622Not Applicable
Pressure Injury Prevention in AE and PFC
NCT00742183Not Applicable
Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®
NCT01790763Phase 2
Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3